PRICING THE MEDICINES IN THE PHARMACEUTICAL BENEFIT SCHEME (PBS).
DO THE CLINICAL CHARACTERISTICS MATTER?
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Poster
- By: AL SHAYBAN, Dhfer (Ministry of Health, Health Economics and Policy, Tucson, United States)
- Co-author(s): Dhfer Al Shayban
Prices of drugs are becoming the focus of much debate in the world. It's believed that the prices of drugs are based some characteristics (e.g. dosage form, frequency).
This study was a cross sectional study covering all the prices of anti-ulcer drugs that listed in the PBS. To assess the likelihood of the impact of each characteristic of an.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.